{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:31:38Z","timestamp":1790242298366,"version":"4.1.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00444","type":"journal-article","created":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T02:21:06Z","timestamp":1552357266000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":97,"title":["Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52\/TRIM21 Antibody Detection in Autoimmune Diseases"],"prefix":"10.3389","volume":"10","author":[{"given":"Ailsa","family":"Robbins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Hentzien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Segolene","family":"Toquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Didier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Servettaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bach-Nga","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/08820139309063402","article-title":"Clinical relevance of antibodies to Ro\/SS-A and La\/SS-B in subacute cutaneous lupus erythematosus and related conditions","volume":"22","author":"Zappi","year":"1993","journal-title":"Immunol Invest"},{"key":"B2","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.autrev.2009.02.010","article-title":"Latest update on the Ro\/SS-A autoantibody system","volume":"8","author":"Schulte-Pelkum","year":"2009","journal-title":"Autoimmun Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1128\/CDLI.8.5.922-925.2001","article-title":"New coupled-particle light-scattering assay for detection of Ro\/SSA (52 and 60 kilodaltons) and La\/SSB autoantibodies in connective tissue diseases","volume":"8","author":"Bizzaro","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jaut.2012.01.014","article-title":"The immunobiology of Ro52 (TRIM21) in autoimmunity: a critical review","volume":"39","author":"Oke","year":"2012","journal-title":"J Autoimmun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1084\/jem.20090585","article-title":"Loss of the lupus autoantigen Ro52\/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway","volume":"206","author":"Espinosa","year":"2009","journal-title":"J Exp Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/ni.2492","article-title":"The E3 ubiquitin ligase TRIM21 negatively regulates the innate immune response to intracellular double-stranded DNA","volume":"14","author":"Zhang","year":"2013","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3389\/fimmu.2017.00651","article-title":"TWEAK\/Fn14 activation participates in Ro52-mediated photosensitization in cutaneous lupus erythematosus","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.autrev.2005.10.004","article-title":"The Ro 60 kDa autoantigen comes into focus: interpreting epitope mapping experiments on the basis of structure","volume":"5","author":"Wolin","year":"2006","journal-title":"Autoimmun Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"Rahman","year":"2008","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/art.1780370113","article-title":"Clinical significance of antibodies to native or denatured 60-kd or 52-kd Ro\/SS-A proteins in Sj\u00f6gren's syndrome","volume":"37","author":"Tsuzaka","year":"1994","journal-title":"Arthritis Rheum"},{"key":"B11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1136\/ard.61.10.929","article-title":"Anti-Ro52 reactivity is an independent and additional serum marker in connective tissue disease","volume":"61","author":"Peene","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.autrev.2011.03.004","article-title":"Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: results of a multicentric study","volume":"10","author":"Ghillani","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1172\/JCI114208","article-title":"Acquired congenital heart block","volume":"84","author":"Buyon","year":"1989","journal-title":"J Clin Invest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.autrev.2010.09.005","article-title":"Clinical and laboratory aspects of Ro\/SSA-52 autoantibodies","volume":"10","author":"Defendenti","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B15","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/08916934.2012.732131","article-title":"Clinical associations of anti-SSA\/Ro60 and anti-Ro52\/TRIM21 antibodies: Diagnostic utility of their separate detection","volume":"46","author":"Men\u00e9ndez","year":"2013","journal-title":"Autoimmunity."},{"key":"B16","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/pgmj.2009.089656","article-title":"Diagnostic utility of anti-Ro52 detection in systemic autoimmunity","volume":"86","author":"Dugar","year":"2010","journal-title":"Postgrad Med J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/rheumatology\/kep145","article-title":"Clinical significance of anti-Ro\/SSA-52 kDa antibodies: a retrospective monocentric study","volume":"48","author":"Hervier","year":"2009","journal-title":"Rheumatol Oxf Engl"},{"key":"B18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.revmed.2003.11.009","article-title":"Auto-antibodies to anti-ENA SSA\/RO (52 and 60 kDa): an auto-immunity laboratory's experience","volume":"25","author":"Bahon-Riedinger","year":"2004","journal-title":"Rev Med Interne"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1186\/ar3763","article-title":"Clinical significance of antibodies to Ro52\/TRIM21 in systemic sclerosis","author":"Hudson","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00296-017-3718-1","article-title":"A review of the role and clinical utility of anti-Ro52\/TRIM21 in systemic autoimmunity","volume":"37","author":"Lee","year":"2017","journal-title":"Rheumatol Int"},{"key":"B21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/rheumatology\/kev300","article-title":"Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease","volume":"55","author":"Gunnarsson","year":"2016","journal-title":"Rheumatol Oxf Engl"},{"key":"B22","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3389\/fimmu.2018.00541","article-title":"Autoantibodies associated with connective tissue diseases: what meaning for clinicians?","volume":"9","author":"Didier","year":"2018","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14397595.2017.1374235","article-title":"Anti-Ro52 antibody level is an important marker of fetal congenital heart block risk in anti-Ro\/SSA antibody positive pregnancy","volume":"28","author":"Miyasato-Isoda","year":"2017","journal-title":"Mod Rheumatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e003419","DOI":"10.1161\/CIRCEP.115.003419","article-title":"Arrhythmogenicity of anti-Ro\/SSA antibodies in patients with torsades de pointes","volume":"9","author":"Lazzerini","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/jcp.2006.040360","article-title":"Specific testing for \u201cisolated\u201d anti-52 kDa SSA\/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value","volume":"60","author":"Langguth","year":"2007","journal-title":"J Clin Pathol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3109\/08916930008994077","article-title":"Comparison of the anti-Ro\/SSA autoantibody profile between patients with primary and secondary Sj\u00f6gren's syndrome","volume":"32","author":"G\u00e1l","year":"2000","journal-title":"Autoimmunity."},{"key":"B27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00296-010-1790-x","article-title":"The prevalence and the clinical relevance of anti-Ro52 in Korean patients with primary Sj\u00f6gren's syndrome","volume":"32","author":"Song","year":"2012","journal-title":"Rheumatol Int"},{"key":"B28","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2007.10.001","article-title":"Antiphospholipid antibodies, antiphospholipid syndrome and infections","volume":"7","author":"S\u00e8ne","year":"2008","journal-title":"Autoimmun Rev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jclinpath-2015-203587","article-title":"Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases","volume":"71","author":"Murng","year":"2017","journal-title":"J Clin Pathol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/s10165-008-0028-1","article-title":"Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period","volume":"18","author":"Hayashi","year":"2008","journal-title":"Mod Rheumatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.reuma.2015.10.010","article-title":"Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain","volume":"12","author":"Menor Almagro","year":"2016","journal-title":"Reumatol Clin"},{"key":"B32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.imlet.2014.04.009","article-title":"Anti-ENA profiles related with anti-SS-A\/Ro","volume":"161","author":"Gonz\u00e1lez","year":"2014","journal-title":"Immunol Lett"},{"key":"B33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1365-3083.2002.01072","article-title":"Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sj\u00f6gren's syndrome","volume":"56","author":"Ohlsson","year":"2002","journal-title":"Scand J Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.4049\/jimmunol.1202341","article-title":"Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factors","volume":"191","author":"Sj\u00f6strand","year":"2013","journal-title":"J Immunol Baltim Md 1950"},{"key":"B35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fimmu.2015.00412","article-title":"Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014-2015","volume":"6","author":"Chan","year":"2015","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3109\/14397595.2015.1091155","article-title":"Clinical subsets associated with different anti-aminoacyl transfer RNA synthetase antibodies and their association with coexisting anti-Ro52","volume":"26","author":"Yamasaki","year":"2016","journal-title":"Mod Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/ar2276","article-title":"Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes","volume":"9","author":"Koenig","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3899\/jrheum.150844","article-title":"Rituximab in the treatment of Jo1 antibody-associated antisynthetase syndrome: anti-Ro52 positivity as a marker for severity and treatment response","volume":"43","author":"Bauhammer","year":"2016","journal-title":"J Rheumatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1136\/ard.61.12.1090","article-title":"Diagnostic associations in a large and consecutively identified population positive for anti-SSA and\/or anti-SSB: the range of associated diseases differs according to the detailed serotype","volume":"61","author":"Peene","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"B40","first-page":"S177","article-title":"Anti-SSA\/Ro52 autoantibodies in scleroderma: results of an observational, cross-sectional study","volume":"32","author":"S\u00e1nchez-Montalv\u00e1","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"B41","first-page":"S131","article-title":"Monospecific anti-Ro52\/TRIM21 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjects: evidence of an association with interstitial lung disease and worse survival","volume":"33","author":"Wodkowski","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.iy.05.040187.000545","article-title":"Rheumatoid factor and immune networks","volume":"5","author":"Carson","year":"1987","journal-title":"Annu Rev Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1172\/JCI115007","article-title":"New roles for rheumatoid factor","volume":"87","author":"Carson","year":"1991","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.autrev.2010.09.001","article-title":"The meaning of anti-Ro and anti-La antibodies in primary Sj\u00f6gren's syndrome","volume":"10","author":"Hern\u00e1ndez-Molina","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/0961203306073135","article-title":"Fine specificity of the Ro\/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun","volume":"16","author":"Popovic","year":"2007","journal-title":"Lupus."},{"key":"B46","doi-asserted-by":"publisher","first-page":"832789","DOI":"10.1155\/2013\/832789","article-title":"Common and specific associations of anti-SSA\/Ro60 and anti-Ro52\/TRIM21 antibodies in systemic lupus erythematosus","volume":"2013","author":"Men\u00e9ndez","year":"2013","journal-title":"Sci World J."},{"key":"B47","first-page":"686","article-title":"Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sj\u00f6gren's syndrome","volume":"30","author":"Retamozo","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/01.bor.0000135452.62800.8f","article-title":"Antinuclear autoantibodies in systemic lupus erythematosus","volume":"16","author":"Sawalha","year":"2004","journal-title":"Curr Opin Rheumatol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/ar3787","article-title":"Congenital heart block: evidence for a pathogenic role of maternal autoantibodies","volume":"14","author":"Ambrosi","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"B50","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","article-title":"The clinical spectrum of autoimmune congenital heart block","volume":"11","author":"Brito-Zer\u00f3n","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"B51","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/art.1780330307","article-title":"Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sj\u00f6gren's syndrome","volume":"33","author":"Ben-Chetrit","year":"1990","journal-title":"Arthritis Rheum"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00444\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T02:21:10Z","timestamp":1552357270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00444\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":51,"alternative-id":["10.3389\/fimmu.2019.00444"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00444","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]},"article-number":"444"}}